About Michael

Michael Ninburg has served as Executive Director of the Hepatitis Education Project since 2001, a U.S.-based organization dedicated to supporting hepatitis patients.

Throughout his career, Michael has served as consultant to a variety of governmental agencies and multilateral organizations, including the World Health Organization, the Pan American Health Organization and the U.S. Department of Health and Human Services. He previously served as a WHA Regional Board Member and Michael has been recognized for his leadership by numerous organizations including the French Ministry of Foreign Affairs, the White House Office of National AIDS Policy and the Office of National Drug Control Policy.

This speaker will be presenting at the following session(s)

  • Strategic direction 5: innovation for acceleration

    Golden Hall

    Day: 3 November

    Time: 13:30

    Innovation can help drive towards the overall objective of hepatitis elimination in a wide range of settings. This innovation session will highlight innovations related to hepatitis B and C products, programs and policies.

    Chairs: Dr. Joseph Tucker, University of North Carolina, USA and Dr. Francesco Marinucci, FIND

    Presentations:

    • Introduction.
    • Michael Ninburg, World Hepatitis Alliance
    • Decentralization of hepatitis services and the ECHO experience.
    • Dr. Henry Cohen, ECHO Project, Uruguay
    • Innovation panel.
    • − Identifying the optimal care model for HCV care in Cambodia, and overcoming barriers to decentralization and scale-up: Médecins Sans Frontières’ pilot program
      − End Hep C SF: HCV Elimination by Prioritizing Engagement of Marginalized Populations
      − Hepatitis Nurse Co-ordinator Treatment Monitoring Model’ for improved treatment outcomes at low cost in India
      − “Little HepB Hero” – the making of children hepatitis B ambassadors in families and community
      − Online-mediated HCV-RNA home-based testing to reduce incidence of hepatitis C virus infection among men who have sex with men in Amsterdam, The Netherlands – an initiative of the MC Free project
      − Innovative approaches towards a free village from viral hepatitis in Egypt

    Session objectives:

    • Learn the importance of innovation in developing hepatitis B and C control programs, policies and products.
    • Understand new products for hepatitis B and C control that could accelerate detection, treatment and retention.
    • Discuss new policies for expanding access to hepatitis B and C testing, treatment and prevention strategies.
    • Learn about new programs and public health interventions to optimize comprehensive hepatitis care.